Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 3 | 2019 | 22 | 0.700 |
Why?
|
| Obesity, Morbid | 2 | 2019 | 30 | 0.560 |
Why?
|
| Weight Loss | 2 | 2019 | 137 | 0.420 |
Why?
|
| Macular Degeneration | 1 | 2013 | 31 | 0.390 |
Why?
|
| Vitamin K | 1 | 2012 | 9 | 0.370 |
Why?
|
| Parenteral Nutrition | 1 | 2012 | 15 | 0.370 |
Why?
|
| Warfarin | 1 | 2012 | 67 | 0.350 |
Why?
|
| Anticoagulants | 1 | 2012 | 122 | 0.340 |
Why?
|
| Aging | 1 | 2013 | 783 | 0.270 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 89 | 0.180 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 48 | 0.140 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2015 | 14 | 0.140 |
Why?
|
| Protein Multimerization | 2 | 2015 | 115 | 0.130 |
Why?
|
| Middle Aged | 6 | 2019 | 12222 | 0.130 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2015 | 13 | 0.120 |
Why?
|
| Plant Proteins | 1 | 2015 | 102 | 0.110 |
Why?
|
| Vibrio | 1 | 2014 | 19 | 0.110 |
Why?
|
| Leptospira | 1 | 2014 | 27 | 0.110 |
Why?
|
| Vitreous Body | 1 | 2013 | 10 | 0.100 |
Why?
|
| Retinaldehyde | 1 | 2013 | 15 | 0.100 |
Why?
|
| Injections | 1 | 2013 | 42 | 0.100 |
Why?
|
| Receptors, Adrenergic | 4 | 1979 | 10 | 0.100 |
Why?
|
| Vitamins | 1 | 2013 | 81 | 0.090 |
Why?
|
| Visual Acuity | 1 | 2013 | 111 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 234 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 1979 | 35 | 0.090 |
Why?
|
| Female | 6 | 2019 | 24698 | 0.090 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 9 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 183 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2012 | 30 | 0.090 |
Why?
|
| Zinc | 1 | 2013 | 131 | 0.090 |
Why?
|
| Aminoglycosides | 1 | 2011 | 6 | 0.090 |
Why?
|
| Serum Albumin | 1 | 2012 | 59 | 0.090 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2011 | 5 | 0.090 |
Why?
|
| Drug Resistance | 1 | 2012 | 96 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 375 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2013 | 213 | 0.090 |
Why?
|
| Comorbidity | 1 | 2013 | 737 | 0.090 |
Why?
|
| Drug Monitoring | 1 | 2011 | 69 | 0.080 |
Why?
|
| Life Style | 1 | 2013 | 334 | 0.080 |
Why?
|
| Obesity | 1 | 2018 | 1151 | 0.080 |
Why?
|
| Male | 8 | 2019 | 23409 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 595 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2013 | 925 | 0.080 |
Why?
|
| Humans | 7 | 2019 | 43102 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 432 | 0.070 |
Why?
|
| Aged | 3 | 2019 | 8214 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2013 | 2544 | 0.060 |
Why?
|
| Adult | 4 | 2019 | 13872 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 2853 | 0.060 |
Why?
|
| Risk Factors | 1 | 2013 | 3994 | 0.050 |
Why?
|
| Crystallography, X-Ray | 2 | 2015 | 280 | 0.050 |
Why?
|
| Arabidopsis | 2 | 2015 | 103 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2015 | 506 | 0.050 |
Why?
|
| United States | 1 | 2013 | 5205 | 0.050 |
Why?
|
| Adolescent | 1 | 2013 | 6081 | 0.050 |
Why?
|
| Dextroamphetamine | 2 | 1979 | 9 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2015 | 876 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 73 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 9 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 33 | 0.040 |
Why?
|
| Calibration | 1 | 2018 | 63 | 0.040 |
Why?
|
| Simvastatin | 1 | 2018 | 29 | 0.040 |
Why?
|
| Cholesterol | 1 | 2019 | 232 | 0.030 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1977 | 15 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2018 | 169 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 465 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 241 | 0.030 |
Why?
|
| Phloem | 1 | 2015 | 2 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1063 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2015 | 69 | 0.030 |
Why?
|
| Brain | 3 | 1979 | 1472 | 0.030 |
Why?
|
| Arabidopsis Proteins | 1 | 2015 | 46 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 182 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 204 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1600 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1081 | 0.030 |
Why?
|
| Movement | 1 | 2014 | 119 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2014 | 416 | 0.020 |
Why?
|
| Glucose | 1 | 2014 | 244 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 307 | 0.020 |
Why?
|
| Alprenolol | 3 | 1978 | 3 | 0.020 |
Why?
|
| Pharmacists | 1 | 2011 | 61 | 0.020 |
Why?
|
| Rubidium | 1 | 1978 | 6 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 1978 | 25 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1285 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 1977 | 10 | 0.020 |
Why?
|
| Heart | 1 | 1977 | 184 | 0.010 |
Why?
|
| Rats | 4 | 1979 | 3735 | 0.010 |
Why?
|
| Microsomes | 2 | 1977 | 55 | 0.010 |
Why?
|
| Kinetics | 2 | 1979 | 695 | 0.010 |
Why?
|
| Doxepin | 1 | 1977 | 1 | 0.010 |
Why?
|
| Iprindole | 1 | 1977 | 1 | 0.010 |
Why?
|
| Desipramine | 1 | 1977 | 13 | 0.010 |
Why?
|
| Animals | 5 | 1979 | 16992 | 0.010 |
Why?
|
| Cocaine | 1 | 1979 | 251 | 0.010 |
Why?
|
| Ouabain | 1 | 1978 | 15 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1978 | 25 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1978 | 27 | 0.000 |
Why?
|
| Radioisotopes | 1 | 1978 | 17 | 0.000 |
Why?
|
| Triiodothyronine | 1 | 1977 | 36 | 0.000 |
Why?
|
| Melanoma | 1 | 1978 | 110 | 0.000 |
Why?
|
| Binding Sites | 1 | 1977 | 671 | 0.000 |
Why?
|
| Myocardium | 1 | 1977 | 263 | 0.000 |
Why?
|
| Dihydroalprenolol | 1 | 1979 | 6 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1979 | 97 | 0.000 |
Why?
|
| Cyclic AMP | 1 | 1979 | 127 | 0.000 |
Why?
|
| Mice | 1 | 1978 | 6644 | 0.000 |
Why?
|